Clay B Siegall Immunome Inc. (IMNM) insider trading activity

Clay B Siegall is President and CEO of Immunome Inc.. Currently has a direct ownership of 669,636 shares of IMNM, which is worth approximately $6.37 Million. The most recent transaction as insider was on Jan 31, 2025, when has been sold 150,000 shares (Common Stock) at a price of $7.75 per share, resulting in proceeds of $1,162,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 670K

28.87% 3M change

109.5% 12M change

Total Value Held $6.37 Million

CLAY B SIEGALL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2025	BUY Open market or private purchase	$1,162,500 $7.75 p/Share	150,000 Added 18.3%	669,636 Common Stock
Nov 22 2024	BUY Open market or private purchase	$331,962 $9.78 p/Share	33,943 Added 6.13%	519,636 Common Stock
Nov 21 2024	BUY Open market or private purchase	$630,183 $9.54 p/Share	66,057 Added 11.97%	485,693 Common Stock
May 21 2024	BUY Open market or private purchase	$281,580 $13.78 p/Share	20,434 Added 4.64%	419,636 Common Stock
May 20 2024	BUY Open market or private purchase	$1,106,763 $13.91 p/Share	79,566 Added 16.62%	399,202 Common Stock
Oct 02 2023	BUY Open market or private purchase	$999,995 $5.91 p/Share	169,204 Added 34.61%	319,636 Common Stock

Also insider at

SGEN

Seagen Inc. Healthcare

President & CEO

NRIX

Nurix Therapeutics, Inc. Healthcare

Director

TALS

Talaris Therapeutics, Inc. Healthcare

Director

STTK

Shattuck Labs, Inc. Healthcare

CBS

Clay B Siegall

President and CEO

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Value

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immunome Inc.

Track Activities on IMNM

Account